Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 172 for “"Subtilisin"”.

  1. High pressure crystallization of Purafect® subtilisin

    … study the effect of high pressure on kinetics of subtilisin crystallization and to use high pressure as a means to better understand the mechanism of crystallization;It is known that the effect of hydrostatic pressure on conformation varies with the protein being studied. To determine the effect …

    iastate Repository record for High pressure crystallization of Purafect® subtilisin (opens in a new tab)

  2. Characterization of subtilisin-like serine proteases in trichomonas vaginalis

    … infection found worldwide. In this study, subtilisin-like serine proteases (subtilases) were examined for their putative role in cell viability. Published data of other eukaryotic protozoan parasites confirm the importance of subtilases for adhesion and invasion. Serine protease inhibitor …

    u-pacific Repository record for Characterization of subtilisin-like serine proteases in trichomonas vaginalis (opens in a new tab)

  3. The New Role of Proprotein Convertase Subtilisin/Kexin Type 9: A Connection of Proprotein Convertase Subtilisin/Kexin Type 9, Apolipoprotein B, and Autophagy

    … via LDL receptor (LDLR). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a newly discovered gene, playing an important role in LDL metabolism. Gain-of-function mutations of PCSK9 lead to hypercholesterolemia and loss-of-function mutations of PCSK9 are associated with decrease of LDL …

    uthsc Repository record for The New Role of Proprotein Convertase Subtilisin/Kexin Type 9: A Connection of Proprotein Convertase Subtilisin/Kexin Type 9, Apolipoprotein B, and Autophagy (opens in a new tab)

  4. Conversion of subtilisin E to thiolsubtilisin by site-directed mutagenesis

    … a procedure of site specific mutagenesis of subtilisin E for reducing its proteolytic activity while retaining its ligase activity in peptide synthesis. A host-vector system was chosen to conduct the DNA manipulation and the gene expression. Subtilisin B gene (aprE) cloned on the plasmid DNA …

    ubc Repository record for Conversion of subtilisin E to thiolsubtilisin by site-directed mutagenesis (opens in a new tab) Download PDF for Conversion of subtilisin E to thiolsubtilisin by site-directed mutagenesis (opens in a new tab)

  5. Interactions Between Hepatitis C Virus and Proprotein Convertase Subtilisin/Kexin Type 9

    … patients. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease primarily produced in the liver. Its gene expression can be regulated by several transcription factors, such as sterol-regulatory element binding proteins (SREBPs), hepatocyte nuclear factor …

    sask Repository record for Interactions Between Hepatitis C Virus and Proprotein Convertase Subtilisin/Kexin Type 9 (opens in a new tab)

  6. PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9)AND GLUCOSE METABOLISM: WHICH CONNECTION?

    PCSK9 (proprotein convertase subtilisin/kexin type 9) and glucose metabolism: which connection? Background: PCSK9 (proprotein convertase subtilisin/kexin type 9), is a protein, mainly synthesized and secreted by the liver, which binds to specific target proteins and escorts them towards lysosomes …

    milano Repository record for PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9)AND GLUCOSE METABOLISM: WHICH CONNECTION? (opens in a new tab)

  7. The Role of Proprotein Convertase Subtilisin/Kexin Type 6 In Colitis and Behavior

    Background: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a protease that is localized primarily on the cell surface and induces protein precursor cleavage to produce mature proteins. PCSK6 is upregulated in Inflammatory Bowel Disease (IBD) and mental diseases such as Alzheimer's disease …

    tamu Repository record for The Role of Proprotein Convertase Subtilisin/Kexin Type 6 In Colitis and Behavior (opens in a new tab) Embargoed until 2027-12-01

  8. The Role of Proprotein Convertase Subtilisin/Kexin Type 6 In Colitis and Behavior

    Background: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a protease that is localized primarily on the cell surface and induces protein precursor cleavage to produce mature proteins. PCSK6 is upregulated in Inflammatory Bowel Disease (IBD) and mental diseases such as Alzheimer's disease …

    tamu Repository record for The Role of Proprotein Convertase Subtilisin/Kexin Type 6 In Colitis and Behavior (opens in a new tab) Embargoed until 2027-12-01

  9. The Role of Proprotein Convertase Subtilisin/Kexin Type 6 In Colitis and Behavior

    Background: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a protease that is localized primarily on the cell surface and induces protein precursor cleavage to produce mature proteins. PCSK6 is upregulated in Inflammatory Bowel Disease (IBD) and mental diseases such as Alzheimer's disease …

    tamu Repository record for The Role of Proprotein Convertase Subtilisin/Kexin Type 6 In Colitis and Behavior (opens in a new tab) Embargoed until 2027-12-01

  10. The Role of Proprotein Convertase Subtilisin/Kexin Type 6 In Colitis and Behavior

    Background: Proprotein convertase subtilisin/kexin-6 (PCSK6) is a protease that is localized primarily on the cell surface and induces protein precursor cleavage to produce mature proteins. PCSK6 is upregulated in Inflammatory Bowel Disease (IBD) and mental diseases such as Alzheimer's disease …

    tamu Repository record for The Role of Proprotein Convertase Subtilisin/Kexin Type 6 In Colitis and Behavior (opens in a new tab) Embargoed until 2027-12-01

  11. Cost-effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: An Economic Evaluation

    … lipid lowering therapy. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are emerging pharmacological treatments for managing patients with these conditions. Therefore, the goal of this thesis is to assess the cost-effectiveness of PCSK9 inhibitors for the treatment of elevated …

    calgary Repository record for Cost-effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: An Economic Evaluation (opens in a new tab)

  12. PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, ATHEROSCLEROSIS AND EXTRACELLULAR VESICLES ¿ EXPERIMENTAL AND CLINICAL EVIDENCE

    … vesicles (EVs). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is expressed and secreted by VSMCs. This study aimed to unravel the role of PCSK9 on VSMCs-derived EVs in terms of content and functionality. EVs were isolated from human VSMCs overexpressing human PCSK9 …

    milano Repository record for PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, ATHEROSCLEROSIS AND EXTRACELLULAR VESICLES ¿ EXPERIMENTAL AND CLINICAL EVIDENCE (opens in a new tab)

  13. Activity of Analogs of Anticancer Drugs on the Serine Protease Enzymes Subtilisin and Chymotrypsin

    … for the anticancer activity. Chymotrypsin and subtilisin are serine proteases that have a histidine residue in the active site. We are investigating the inhibition of the digestive enzymes chymotrypsin and subtilisin by analogs of the anticancer drug cisplatin and trying to discern trends in …

    wku-diss Repository record for Activity of Analogs of Anticancer Drugs on the Serine Protease Enzymes Subtilisin and Chymotrypsin (opens in a new tab)

  14. CLINICAL AND EXPERIMENTAL EVIDENCES OF DIRECT VASCULAR EFFECT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9

    Proprotein Convertase Subtilisin Kexin type 9 (PCSK9), together with LDLR and APOB genes, had been identified as the third gene associated with Familial Hypercholesterolemia (FH). Secreted PCSK9 in fact, targets the hepatic LDL receptor (LDLR) for degradation thus preventing its recycling on the …

    milano Repository record for CLINICAL AND EXPERIMENTAL EVIDENCES OF DIRECT VASCULAR EFFECT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (opens in a new tab)

  15. THE ROLE OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 6 IN PLACENTAL DEVELOPMENT UNDER GESTATIONAL DIABETES

    … 10% of pregnancies. Proprotein convertase subtilisin/kexin-6 (PCSK6) is a protease that processes precursor proteins into active forms. Based on previous reports of PCSK6 expression in the placenta, involvement in embryonic development and vascular remodeling, we hypothesized that PCSK6 …

    tamu Repository record for THE ROLE OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 6 IN PLACENTAL DEVELOPMENT UNDER GESTATIONAL DIABETES (opens in a new tab)

Page 1 of 9